2Balasch J, Tur R, Creus M, et al. Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin- stimulated cycles for prevention of ovarian hyper- stimula- tion syndrome and multiple pregnancy. Gynecol Endocrinol, 1994, 8(1):7-12.
3Itskovitz-Eldor J, Levron J, Kol S. Use of gonadotropin releasing hormone agonist to couse ovulation and prevent the ovarian hyperstimulation syndrome. Clin Obstet Gynecol, 1993, 36(3):701-10.
4Beckers NG, Laven JS, Eijkemans M J, et al. Follicular and luteal phase characteristics following early cessation of gonadotrophinreleasing hormone agonist during ovarian stimulation for in vitro fertilization[J]. Hum Reprod, 2000, 15(1): 43-49.
5Franchin R, Ayoubi JM, Olivennes F, et al. Hormonal influence on the uterine contractility during ovarian stimulation [J ]. Hum Reprod, 2000, 15[Suppl]: 90.
6Asimakopoulos B, Nikolettos N, Nehls B, et al. Gonadotropinreleasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures [J]. Fertil Steril, 2006, 86(3): 636-641.
7Beckers NG, Macklon NS, Eijkemans M J, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment [J]. J Clin Endocrinol Metab, 2003, 88(9): 4186-4192.
8Tavaniotou A, Devroey P. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles [J]. Reprod Biomed Online, 2006, 13(3): 326-330.
9Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials[J]. Hum Reprod, 2002, 17 (9): 2287-2299.
10Ficicioglu C, Gurbuz B, Tasdemir S, et al. High local endometrial effect of vaginal progesterone gel[J]. Gynecol Endocrinol, 2004, 18 (5): 240-243.
